title: Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma.
abstract: OBJECTIVE
  To study the association between immunoreactivity for insulin-like growth factor-1 receptor (IGF-1R) in primary ciliary body and choroidal melanoma and metastatic death in a consecutive, population-based data set.
  
  
  METHODS
  Retrospective, consecutive, population-based cohort study.
  
  
  METHODS
  A total of 167 patients with choroidal and ciliary body melanoma, enucleated from 1972 to 1981, with long-term survival data.
  
  
  METHODS
  Specimens were immunostained by using the avidin-biotinylated peroxidase complex method and polyclonal antibodies to IGF-1R. The percentage of tumour area that was immunopositive was recorded. Survival was assessed by Cox multivariate regression analysis.
  
  
  RESULTS
  The tumour area could be reliably measured from 129 (78%) of the 167 choroidal or ciliary body melanomas. More heavy pigmentation (p = 0.001), larger number of macrophages (p = 0.003) and higher microvascular density (p = 0.060) were associated with a higher percentage of tumour area that was immunopositive for IGF-1R, the reverse being true of extrascleral extension (p = 0.049). No significant association was observed with ciliary body extension, largest basal tumour diameter, cell type, mean diameter of the 10 largest nucleoli, and presence of extravascular matrix loops and networks (p = 0.61-0.96). The percentage of tumour area that was immunopositive for IGF-1R was not associated with survival.
  
  
  CONCLUSIONS
  In our data set, immunoreactivity for IGF-IR did not independently predict metastasis from primary uveal melanoma. Partial loss of antigenicity can not be ruled out as a confounding factor because no frozen sections were available. Results of previous studies have likewise been variable, suggesting that immunohistochemical determination of IGF-1R from formalin-fixed, paraffin-embedded specimens is not practical as a routine test.
authors.affiliation: Ophthalmic Pathology Laboratory, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland. ranaa.aljamal@hus.fi
authors.forename: Rana'a T
authors.initials: RT
authors.lastname: Al-Jamal
authors.forename: Tero
authors.initials: T
authors.lastname: Kivelä
mesh_terms: D003430:Cross-Sectional Studies; D015353:Eye Enucleation; D005500:Follow-Up Studies; D006801:Humans; D007124:Immunoenzyme Techniques; D008545:Melanoma / Q000378:metabolism* / Q000401:mortality / Q000556:secondary; D011379:Prognosis; D016016:Proportional Hazards Models; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D012189:Retrospective Studies; D015996:Survival Rate; D014604:Uveal Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology
chemical_list: D017526:Receptor, IGF Type 1